{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:43:35Z","timestamp":1786221815122,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010722","name":"Harbin Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Heilongjiang Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.brainres.2026.150474","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:50:58Z","timestamp":1784789458000},"page":"150474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A promising therapeutic strategy reduces abnormal A\u03b2 deposition and inhibits neuronal apoptosis via FGF17 ameliorating AD-like neurodegeneration"],"prefix":"10.1016","volume":"1889","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinling","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.brainres.2026.150474_b0005","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s11033-021-06890-0","article-title":"New insights into the role of fibroblast growth factors in Alzheimer's disease","volume":"49","author":"Alam","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"9770","key":"10.1016\/j.brainres.2026.150474_b0010","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer's disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.brainres.2026.150474_b0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2026.150474_b0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1471-4159.2004.02984.x","article-title":"Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosis","volume":"93","author":"Cassina","year":"2005","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.brainres.2026.150474_b0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02740836","article-title":"A potential role for apoptosis in neurodegeneration and Alzheimer's disease","volume":"10","author":"Cotman","year":"1995","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2026.150474_b0030","article-title":"Animal models of metabolic disorders in the study of neurodegenerative diseases: an overview","volume":"14","author":"de Bem","year":"2020","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.brainres.2026.150474_b0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.brainres.2026.150474_b0040","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/mt.2013.289","article-title":"Intrajugular vein delivery of AAV9-RNAi prevents neuropathological changes and weight loss in Huntington's disease mice","volume":"22","author":"Dufour","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainres.2026.150474_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1249320","article-title":"Age-dependent changes on fractalkine forms and their contribution to neurodegenerative diseases","volume":"16","author":"Eugen\u00edn","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.brainres.2026.150474_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.747726","article-title":"A multifaceted approach to optimizing AAV delivery to the brain for the treatment of neurodegenerative diseases","volume":"15","author":"Fischell","year":"2021","journal-title":"Front. Neurosci."},{"issue":"12","key":"10.1016\/j.brainres.2026.150474_b0055","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/mt.2013.211","article-title":"Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS","volume":"21","author":"Foust","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainres.2026.150474_b0060","unstructured":"Fraley, M. E. (2004). Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors. In: US."},{"issue":"2","key":"10.1016\/j.brainres.2026.150474_b0065","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1152\/physrev.00011.2017","article-title":"Neuronal cell death","volume":"98","author":"Fricker","year":"2018","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.brainres.2026.150474_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0322708","article-title":"Overexpression of LINC00672 promotes autophagy in Alzheimer's disease by upregulating GPNMB","volume":"20","author":"Gao","year":"2025","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.brainres.2026.150474_b0075","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13937","article-title":"Fibroblast growth factor 10 ameliorates neurodegeneration in mouse and cellular models of Alzheimer's disease via reducing tau hyperphosphorylation and neuronal apoptosis","volume":"22","author":"Guo","year":"2023","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/j.brainres.2026.150474_b0080","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1084\/jem.20171831","article-title":"BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions","volume":"215","author":"Hu","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.brainres.2026.150474_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119142","article-title":"Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection","volume":"270","author":"Huang","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2026.150474_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176521","article-title":"FGF17 protects cerebral ischemia reperfusion-induced blood-brain barrier disruption via FGF receptor 3-mediated PI3K\/AKT signaling pathway","volume":"971","author":"Huang","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"7910","key":"10.1016\/j.brainres.2026.150474_b0095","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-022-04722-0","article-title":"Young CSF restores oligodendrogenesis and memory in aged mice via Fgf17","volume":"605","author":"Iram","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2026.150474_b0100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4939-7477-1_9","article-title":"Cell death and survival assays","volume":"1709","author":"Kabakov","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.brainres.2026.150474_b0105","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1038\/s41598-025-90925-0","article-title":"Neuroprotective mitochondria targeted small molecule restores synapses and the distribution of synaptic mitochondria in the hippocampus of APP\/PS1 mice","volume":"15","author":"Keller","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2026.150474_b0110","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","article-title":"Caspases in cell death, inflammation, and pyroptosis","volume":"38","author":"Kesavardhana","year":"2020","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.brainres.2026.150474_b0115","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","article-title":"Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer's disease","volume":"18","author":"Khan","year":"2020","journal-title":"Curr. Neuropharmacol."},{"issue":"8","key":"10.1016\/j.brainres.2026.150474_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070356","article-title":"Possible role of the glycogen synthase kinase-3 signaling pathway in trimethyltin-induced hippocampal neurodegeneration in mice","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.brainres.2026.150474_b0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/alzrt265","article-title":"Dietary regulation of PI3K\/AKT\/GSK-3\u03b2 pathway in Alzheimer's disease","volume":"6","author":"Kitagishi","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.brainres.2026.150474_b0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","article-title":"The Y-maze for assessment of spatial working and reference memory in mice","volume":"1916","author":"Kraeuter","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"50","key":"10.1016\/j.brainres.2026.150474_b0135","doi-asserted-by":"crossref","first-page":"17889","DOI":"10.1073\/pnas.0509222102","article-title":"Huntington's disease and neurogenesis: FGF-2 to the rescue?","volume":"102","author":"La Spada","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.brainres.2026.150474_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118664","article-title":"Glycogen synthase kinase-3 signaling in Alzheimer's disease","volume":"1867","author":"Lauretti","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.brainres.2026.150474_bib311","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuroscience.2025.03.009","article-title":"Potential therapeutic targets for Alzheimer\u2019s disease: Fibroblast growth factors and their regulation of ferroptosis, pyroptosis and autophagy","volume":"573","author":"Li","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2026.150474_b0150","first-page":"46","article-title":"GSK-3\u03b2, a pivotal kinase in Alzheimer disease","volume":"7","author":"Llorens-Mart\u00edn","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.brainres.2026.150474_b0155","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.freeradbiomed.2015.02.028","article-title":"Molecular mechanisms linking amyloid \u03b2 toxicity and Tau hyperphosphorylation in Alzheimer\u05f3s disease","volume":"83","author":"Lloret","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.brainres.2026.150474_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.648636","article-title":"PI3K\/AKT signal pathway: a target of natural products in the prevention and treatment of alzheimer's disease and Parkinson's disease","volume":"12","author":"Long","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"17","key":"10.1016\/j.brainres.2026.150474_b0165","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1016\/j.bmc.2018.08.019","article-title":"Novel multi-target compounds in the quest for new chemotherapies against Alzheimer's disease: an experimental and theoretical study","volume":"26","author":"Mart\u00ednez","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"7000","key":"10.1016\/j.brainres.2026.150474_b0170","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.brainres.2026.150474_b0175","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"issue":"s1","key":"10.1016\/j.brainres.2026.150474_b0180","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.3233\/JAD-201178","article-title":"Alzheimer's disease, neural plasticity, and functional recovery","volume":"82","author":"Mercer\u00f3n-Mart\u00ednez","year":"2021","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.brainres.2026.150474_b0185","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s11658-024-00600-x","article-title":"APOE2 protects against A\u03b2 pathology by improving neuronal mitochondrial function through ERR\u03b1 signaling","volume":"29","author":"Ning","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.brainres.2026.150474_b0190","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fnagi.2019.00184","article-title":"Multi-loop model of Alzheimer disease: an integrated perspective on the Wnt\/GSK3\u03b2, \u03b1-synuclein, and type 3 diabetes hypotheses","volume":"11","author":"Norwitz","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.brainres.2026.150474_b0195","doi-asserted-by":"crossref","first-page":"e1535","DOI":"10.7717\/peerj.1535","article-title":"Fibroblast growth factors as tissue repair and regeneration therapeutics","volume":"4","author":"Nunes","year":"2016","journal-title":"PeerJ"},{"issue":"3","key":"10.1016\/j.brainres.2026.150474_b0200","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"issue":"9","key":"10.1016\/j.brainres.2026.150474_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092418","article-title":"The saga of endocrine FGFs","volume":"10","author":"Phan","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.brainres.2026.150474_b0210","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/17460441.2015.1041913","article-title":"Rodent models for Alzheimer's disease drug discovery","volume":"10","author":"Puzzo","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"issue":"4","key":"10.1016\/j.brainres.2026.150474_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040884","article-title":"FGF\/FGFR Pathways in Multiple Sclerosis and in its Disease Models","volume":"10","author":"Rajendran","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.brainres.2026.150474_b0220","doi-asserted-by":"crossref","DOI":"10.3390\/ph15050545","article-title":"Unveiling the multitarget anti-Alzheimer drug discovery landscape: a bibliometric analysis","volume":"15","author":"Sampietro","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.brainres.2026.150474_b0225","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1601-183X.2007.00357.x","article-title":"Abnormal social behaviors in mice lacking Fgf17","volume":"7","author":"Scearce-Levie","year":"2008","journal-title":"Genes Brain Behav."},{"issue":"1","key":"10.1016\/j.brainres.2026.150474_b0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12031-020-01621-9","article-title":"Anti-aging Klotho Protects SH-SY5Y Cells against Amyloid \u03b21-42 neurotoxicity: involvement of Wnt1\/pCREB\/Nrf2\/HO-1 signaling","volume":"71","author":"Sedighi","year":"2021","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.brainres.2026.150474_b0235","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"12","key":"10.1016\/j.brainres.2026.150474_b0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.59556\/japi.72.0755","article-title":"Current update on promising new anti-Alzheimer's drugs in different phases of clinical development: where exactly are we lacking?","volume":"72","author":"Sharma","year":"2024","journal-title":"J. Assoc. Physicians India"},{"issue":"12","key":"10.1016\/j.brainres.2026.150474_b0245","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1007\/s11064-021-03418-7","article-title":"Apoptotic pathways and Alzheimer's disease: probing therapeutic potential","volume":"46","author":"Sharma","year":"2021","journal-title":"Neurochem. Res."},{"issue":"6","key":"10.1016\/j.brainres.2026.150474_b0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065663","article-title":"Genome-wide identification and characterization of bovine fibroblast growth factor (FGF) gene and its expression during adipocyte differentiation","volume":"24","author":"Sheng","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.brainres.2026.150474_b0255","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2967\/jnumed.121.262239","article-title":"Alzheimer Disease: standard of diagnosis, treatment, care, and prevention","volume":"63","author":"Teipel","year":"2022","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.brainres.2026.150474_b0260","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/gt.2017.9","article-title":"Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1(G93A) ALS rat but has adverse side effects","volume":"24","author":"Thomsen","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.brainres.2026.150474_b0265","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fncel.2020.00019","article-title":"GSK3\u03b2 and tau protein in Alzheimer's disease and epilepsy","volume":"14","author":"Toral-Rios","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"7","key":"10.1016\/j.brainres.2026.150474_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076518","article-title":"Inflammatory processes in Alzheimer's disease-pathomechanism, diagnosis and treatment: a review","volume":"24","author":"Twarowski","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2026.150474_b0275","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mcn.2016.10.007","article-title":"Systemic application of AAV vectors targeting GFAP-expressing astrocytes in Z-Q175-KI Huntington's disease mice","volume":"77","author":"Vagner","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.brainres.2026.150474_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115923","article-title":"New insights into glycogen synthase kinase-3: a common target for neurodegenerative diseases","volume":"218","author":"Wang","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.brainres.2026.150474_b0285","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11064-025-04350-w","article-title":"Improvements in Exercise for Alzheimer's disease: highlighting FGF21-induced cerebrovascular protection","volume":"50","author":"Wang","year":"2025","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2026.150474_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.jare.2025.06.024","article-title":"FGFs\/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems","author":"Wang","year":"2025","journal-title":"J. Adv. Res."},{"issue":"6","key":"10.1016\/j.brainres.2026.150474_b0295","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.24272\/j.issn.2095-8137.2024.274","article-title":"Animal models of Alzheimer's disease: current strategies and new directions","volume":"45","author":"Wang","year":"2024","journal-title":"Zool. Res."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2026.150474_b0300","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0925-4773(99)00034-9","article-title":"Genomic structure, mapping, activity and expression of fibroblast growth factor 17","volume":"83","author":"Xu","year":"1999","journal-title":"Mech. Dev."},{"issue":"1","key":"10.1016\/j.brainres.2026.150474_b0305","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/gt.2009.113","article-title":"AAV9-mediated erythropoietin gene delivery into the brain protects nigral dopaminergic neurons in a rat model of Parkinson's disease","volume":"17","author":"Xue","year":"2010","journal-title":"Gene Ther."},{"issue":"12","key":"10.1016\/j.brainres.2026.150474_b0310","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1038\/s41380-022-01693-6","article-title":"Adeno-associated virus (AAV) 9-mediated gene delivery of Nurr1 and Foxa2 ameliorates symptoms and pathologies of Alzheimer disease model mice by suppressing neuro-inflammation and glial pathology","volume":"28","author":"Yang","year":"2023","journal-title":"Mol. Psychiatry"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899326003367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899326003367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:09:34Z","timestamp":1786219774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899326003367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":62,"alternative-id":["S0006899326003367"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2026.150474","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A promising therapeutic strategy reduces abnormal A\u03b2 deposition and inhibits neuronal apoptosis via FGF17 ameliorating AD-like neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2026.150474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150474"}}